Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 2.4 million
▲ 65% vs 2024
Profit
Caution€ -1.1 million
▼ 275% vs 2024
Debts
High€ 4.7 million
▲ 2% vs 2024
NUTRIPHYT from Gent, company number BE0478698859, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year NUTRIPHYT recorded a gross margin of € 2.4 million and equity of € 453,740. Compared with financial year 2024, the result moved from € -286,399 to € -1.1 million. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
What happened at NUTRIPHYT?
What happened at NUTRIPHYT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Smard BV stepped down as director. NBB
- Erudite BV stepped down as director. NBB
- Erudite.health BV stepped down as director. NBB
- Lucalot BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- Hadewijch Devriendt stepped down as director. NBB
- Pure Lynn BV stepped down as director. NBB
- Lucalot BV became a director. NBB
In short
From € 364,554 profit in 2021 to € 1.1 million loss in 2025.
Paid € 350,262 in corporate taxes since 2021.
Best year ever: 2021, with € 364,554 profit.
On average € 107,300 of value added per employee in 2025.
A new publication or filing at NUTRIPHYT? We notify you, reason included.
Follow NUTRIPHYTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Nutriphyt Nederland BV itself.
Directors
According to the 2025 annual accounts
since 2024 · until 2029
Hadewijch Devriendt
Director
since 2023 · until 2025
Managing director · represented by Louis Declerck
Also active at: T.DIFFUSION, S.A. Laboratoires Pharmaceutiques Trenker, ROBINWOOD +4 more
since 2023 · until 2029
Managing director · represented by Herlinde Devriendt
since 2023 · until 2025
Director · represented by Charles Declerck
since 2024 · until 2029
Director · represented by Filip Meire
Also active at: Ace Law, Erudite.Health, Complissimo
since 2025 · until 2029
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1084 box .0204
9051 Gent
Kortrijksesteenweg 1084/0204
9051 Gent
Active since 18 November 2002
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
CANTILLANA
€ 33.8 million revenue · 2025
Cantillana Group
XEOS MEDICAL
€ -1.5 million gross margin · 2025
Erudite.Health same network
€ -485,799 gross margin · 2025
Fire Engineered Solutions
€ 2.7 million gross margin · 2025
+6 more
Details
- Company number
- 0478.698.859
- VAT number
- BE 0478.698.859
- Registered office
- Kortrijksesteenweg 1084 bus .0204, 9051 Gent
- Names & denominations
- NUTRIPHYT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 October 2002
- Peppol
- Active · Active since 26 Sept 2025
- Activities · NACE
Overige gespecialiseerde groothandel in voedingswaren
Groothandel in andere voedingsmiddelen, neg